Probiotics may alleviate symptoms of hay fever, which may be related to bacteria in our gut and nose.

Published Date: 26 Apr 2023

The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.

Read Full News

Latest News

Radiation Boost Linked to Better Survival in Rectal Cancer

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

Creatinine Assay Bias Affects MELD Scoring

Bilirubin interference in commonly used creatinine assays artificially inflates MELD scores in liver transplant candidates, a study reports.

EHR Marker May Help Curb Risk for Liver Transplant Rejection

A remote intervention aimed at improving medication adherence may reduce organ rejection in liver transplant recipients at high risk.

Altimmune Drug Cuts Heavy Drinking in Mid-stage Trial for Alcohol Use Disorder

Altimmune said on Tuesday its experimental drug helped patients with alcohol use disorder cut back on heavy drinking ⁠in a mid-stage trial, sending the company's shares 10%...

Newer Antibiotics Show No Clear Benefit for Staph Infections

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for non-urinary Staphylococcus aureus infections.

FDA Approves Freenome's Blood Test for Colorectal Cancer Screening

The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way ⁠for partner Abbott to launch it in the U.S. this fall,...

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

A phase 2 trial finds that adding a modest radiation boost improves 9-year survival without increasing toxicity, despite no improvement in pathologic complete response.

Bilirubin interference in commonly used creatinine assays artificially inflates MELD scores in liver transplant candidates, a study reports.

A remote intervention aimed at improving medication adherence may reduce organ rejection in liver transplant recipients at high risk.

Altimmune said on Tuesday its experimental drug helped patients with alcohol use disorder cut back on heavy drinking ⁠in a mid-stage trial, sending the company's shares 10%...

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for non-urinary Staphylococcus aureus infections.

The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way ⁠for partner Abbott to launch it in the U.S. this fall,...

News All Time

Low-Volume PEG Wins for Inpatient Bowel Cleansing

PEG 1 L beats ‘more-is-better’ pre-colonoscopy regimens, demonstrating more high-quality cleansing and greater tolerability than 2-L and 4-L formulations.

Why the Painless Abdominal Bloating in Middle-Age Man?

Admitted for pyelonephritis, but his diagnostic journey is just beginning

Beware Aspiration Risk in Chronic Pot Users

A cautionary tale of gastroparesis-related aspiration in NPO patient with no other risk factors

Unusual Confluence of Two Rare Syndromes Results in Peculiar Symptoms

Interpretation of an ultrasound exam made all the difference in creating a treatment plan

Common Meds Linked to Reduced Immunotherapy Benefit in Lung Cancer Trial

— Results highlight importance of careful evaluation of concurrent medications, researchers say

Q&A: Managing GI Toxicities of Immunotherapy

Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Equitable IBD Care: Improving Interactions With Patients From the LGBTQ+ Community

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Mastering Recent Advances in Targeted Therapy for GEP-NETs

Steatosis and Cardiovascular Events; Golimumab Biosimilar OK'd; Daily Stress and IBS

News and commentary from the world of gastroenterology and hepatology

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

Accumulating evidence of possible benefit warrants randomized trials, experts say

Danish Duo's Maverick African Research Finds Its Moment in RFK Jr.'s Vaccine Policy

"They became more strident in saying that their findings were real," says one expert

FDA OKs First Treatment for Chronic Hepatitis D Infection

In phase III study, patients taking bulevirtide had ALT normalization and steep drops in HDV RNA

Perfusion Preservation Strategy Boosts Liver Transplant Outcomes

Portal-venous hypothermic oxygenated perfusion reduced incidence of early allograft dysfunction

Blood Test for Colon Cancer Screening Gets Guideline Backing

Updated ACS guidance suggests use in those who decline other options

GLP-1s and Chronic Pancreatitis; Hypoglycemia After Bowel Prep; Lower GI Bleeding

News and commentary from the world of gastroenterology and hepatology

Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

Findings "will change the landscape" of treatment, researcher says

Recommended News For You

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

T-DXd Reduces Residual Disease in Early Breast Cancer

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

Report reveals lung cancer is the leading cause of cancer deaths in Florida

Shorter but More Intense RT: A Better Option for HNSCC?

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

Recommended Articles For You

Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options  

Advanced Approaches in Oncology and Patient Outcomes 

Everything You Need to Know About Leiomyomas: A Comprehensive Guide  

Bone Marrow Regenerative Capacity and Hematologic Recovery 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Oncology Drug Shortages Persist, but Continue to Evolve

2.

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

3.

Relationship-building key to addressing oncologist shortages in rural care

4.

Daily physical activity, even at light intensities, linked to lower cancer risk

5.

Waiting for a Sharp Increase in Prostate Cancer Cases.

1.

The Importance of Having a Quick and Effective Heparin Antidote 

2.

Managing Hematoma: A Guide to Prevention and Treatment

3.

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

4.

Improving TIVAP Use: Review of Standardization and Optimization Practices

5.

Navigating the Unknown: How to Cope with Anaplastic Thyroid Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

4.

Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment

5.

Thromboprophylaxis In Medical Settings

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot